HILARY CUTLER: Open Payments
NPI 1548557218 · ARLINGTON, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,137 in 51 payments from 16 companies in 2025. Trend: 2023 $2,491 · 2024 $1,596 · 2025 $1,137
Food & beverage: $1,037Education: $100
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 16 | $415 |
| Janssen Biotech, Inc. | 9 | $178 |
| Lilly USA, LLC | 3 | $77 |
| Galderma Laboratories, L.P. | 3 | $67 |
| Novartis Pharmaceuticals Corporation | 3 | $65 |
| ABBVIE INC. | 3 | $61 |
| Amgen Inc. | 3 | $56 |
| BioWound Solutions, Inc. | 1 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $33 |
| NOBELPHARMA AMERICA, LLC | 2 | $29 |
Products named: Bimzelx, TREMFYA, NEMLUVIO, COSENTYX, OTEZLA, EBGLYSS, bio-ConneKt, SPEVIGO.
Industry payments across WA — which companies pay providers there.
